Who are Onconano's investors?

Onconano's investors include Green Park & Golf Ventures.

How much funding has Onconano raised?

Onconano has disclosed $115M raised across 3 rounds.

Where is Onconano headquartered?

Onconano is headquartered in Dallas, US.

Onconano

Dallas, US · Founded 2014 · 1 known investors

Find your way into Onconano

482 people in our graph share verified history with the Onconano team — schools, employers, funds. One of them is your warm intro.

Benjamin Brockwellunlockedknows Kartik Krishnan · together at The University of Arizona (overlapped)

×3knows the team · via TCU Neeley School of Business

×5knows the team · via Amgen

knows the team · via Columbia University

knows the team · via Five Prime Therapeutics

knows the team · via The University of the South

OncoNano Medicine develops a proprietary nanotechnology platform for cancer therapeutics that targets the acidic tumor microenvironment to improve drug delivery to tumors. The company serves oncology patients and builds a pipeline of therapies designed for more precise cancer treatment.

Biotech Deep Tech Healthtech Medical Devices

Founders & leadership

Melissa Paoloni inExecutiveMelissa Paoloni is Executive Officer at OncoNano Medicine, where she oversees corporate operations, business development, strategic partnerships, and portfolio management. She brings experience in pharmaceutical licensing, clinical development, and investor relations.

Matthew Head inExecutiveHe brings experience in operational finance, commercial banking, and corporate communications across both startup and large corporate environments.

Kartik Krishnan inExecutiveKartik Krishnan is an executive with experience as an academic physician-scientist and clinical leadership roles in biotech, including prior positions in pharmacovigilance and as Chief Executive Officer. He brings expertise in drug development from preclinical through Phase 3 clinical trials, with particular focus on oncology including solid tumors and hematologic malignancies.

Gina Guillem JonesMMS, PhD

Benjamin QuiCFA, CMA

Joydeep GoswamiNamed on SEC filing

Paritosh DhawaleNamed on SEC filing

Alvaro GuillemNamed on SEC filing

Ravi SrinivasanNamed on SEC filing

Board

John DyettBoard director

Yumin QuiBoard director

Brett P. GiroirMD Chairman

Investors · 1

Green Park & Golf VenturesDallas · $500K – $2M

Reported raises · per SEC filings

Form D private placements

$115M disclosed across 3 rounds · 2018–2025

▶$12.7MraisedJun 2025 · 25 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

John DyettDirector
Gina JonesDirector
Melissa PaoloniExecutive Officer
Matthew HeadExecutive Officer
Brett GiroirDirector
Yumin QuiDirector
Kartik KrishnanExecutive Officer, Director

Offering amount: $12.7M
Amount sold: $12.7M
Sales commissions: $634.9K
Placement agents: Salem Partners LLC
First sale: Apr 2025
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$68.4MraisedNov 2021 · 27 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Martin DriscollExecutive Officer, Director
Alvaro GuillemDirector
Yumin QiuDirector
Matthew HeadExecutive Officer
John DyettDirector

Offering amount: $68.4M
Amount sold: $68.4M
Finders' fees: $2.5M
Placement agents: Salem Partners LLC
First sale: Oct 2020
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$33.9MraisedApr 2019 · 39 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Joydeep GoswamiDirector
John DyettDirector
Matthew HeadExecutive Officer
Paritosh DhawaleDirector
Alvaro GuillemDirector
Ravi SrinivasanExecutive Officer, Director

Offering amount: $35.4M
Amount sold: $33.9M
Finders' fees: $600K
Placement agents: Salem Partners LLC
First sale: Mar 2018
Incorporated: Corporation, Delaware, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Onconano do?: OncoNano Medicine develops a proprietary nanotechnology platform for cancer therapeutics that targets the acidic tumor microenvironment to improve drug delivery to tumors. The company serves oncology patients and builds a pipeline of therapies designed for more precise cancer treatment.
Who are Onconano's investors?: Onconano's investors include Green Park & Golf Ventures.
How much funding has Onconano raised?: Onconano has disclosed $115M raised across 3 rounds.
Where is Onconano headquartered?: Onconano is headquartered in Dallas, US.